Pulmotect, Inc.
Clinical trials sponsored by Pulmotect, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New inhaled drug aims to stop lung infections in vulnerable blood cancer patients Results expected Apr 2027 (estimated)